Fund Holdings — New Leaf Venture Partners, L.L.C.

Total Portfolio Value:
$52.95M
Total Bought:
$0
Total Sold:
$1.01M
Net Transaction:
-$1.01M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Passage Bio, Inc.(PASG)2,497,9222,497,9220$881.8K$19.98M37.74%+$19.10M
Edgewise Therapeutics, Inc.(EWTX)1,030,1611,030,1610$22.66M$13.51M25.51%-$9.16M
Arvinas, Inc.(ARVN)1,585,7211,585,7210$11.13M$11.67M22.04%+$539.1K
Crinetics Pharmaceuticals Inc141,000141,0000$4.73M$4.06M7.66%-$674.0K
Cogent Biosciences, Inc.(COGT)250,765250,7650$1.50M$1.80M3.40%+$298.4K
Rallybio Corporation(RLYB)3,301,6033,301,6030$2.15M$1.12M2.11%-$1.03M
Alector Inc339,569339,5690$417.7K$475.4K0.90%+$57.7K
Iterum Therapeutics PlcSHS345,020345,0200$424.4K$343.3K0.65%-$81.1K
Rocket Pharmaceuticals, Inc.(RCKT)150,7060-150,706$1.01M$0—-$1.01M
Page 1 of 1
New Leaf Venture Partners, L.L.C. — 13F Holdings — Q2 2025 | TickerTrail